Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report
Hemophagocytic lymphohistiocytosis (HLH) is an immune-mediated disorder resulting in hyperactivation of inflammatory cytokines. If left untreated, the uncontrolled inflammatory response can lead to significant tissue injury and potentially life-threatening multi-organ dysfunction. Conventional immun...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2019-07-01
|
| coleção: | Hematology/Oncology and Stem Cell Therapy |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.1016/j.hemonc.2017.07.002 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|